NanoString Technologies, Inc. (NSTG)

Market Cap	432.35M
Revenue (ttm)	127.26M
Net Income (ttm)	-159.54M
Shares Out	46.79M
EPS (ttm)	-3.44
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	31,092
Open	9.29
Previous Close	9.11
Day's Range	9.22 - 9.36
52-Week Range	4.37 - 37.06
Beta	1.59
Analysts	Buy
Price Target	16.90 (+82.9%)
Earnings Date	May 9, 2023

About NSTG

NanoString Technologies, Inc. develops, manufactures, and sells tools for scientific and clinical research in the fields of genomics and proteomics in the Americas, Europe, the Middle East, and the Asia Pacific. The company offers nCounter Analysis System, an automated, multi-application, digital detection, and counting system. It provides nCounter MAX and FLEX systems that include Prep Station, an automated liquid handling component that processes and prepares samples for data collection; and nCounter Digital Analyzer, which collects data from...

• Industry: Medical Instruments & Supplies
• Sector: Healthcare
• IPO Date: Jun 26, 2013
• Employees: 766
• Stock Exchange: NASDAQ
• Ticker Symbol: NSTG

Financial Performance

In 2022, NSTG's revenue was $127.26 million, a decrease of -12.28% compared to the previous year's $145.09 million. Losses were -$159.54 million, 38.4% more than in 2021.

Analyst Forecast

According to 13 analysts, the average rating for NSTG stock is "Buy." The 12-month stock price forecast is $16.9, which is an increase of 82.90% from the latest price.

Price Target

$16.9

(82.90% upside)

Analyst Consensus: Buy